Panacea Life Sciences Holdings, Inc. (PLSH)
OTCMKTS: PLSH · Delayed Price · USD
0.158
-0.031 (-16.19%)
May 3, 2024, 3:41 PM EDT - Market closed

PLSH Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018201720162015
Net Income
-8.02-11.1-6.12-6.99-9.48-4.34-3.86-1.6-0.36
Depreciation & Amortization
1.711.730.970.340.890.410.0500
Other Operating Activities
4.786.971.24-12.843.472.570.64-0.21
Operating Cash Flow
-1.52-2.4-3.92-7.65-5.75-0.47-1.23-0.96-0.57
Capital Expenditures
-0.07-0.24-0.16-3.2-0.540000
Acquisitions
000.010.12-1.50000
Change in Investments
--0.05-0.452.96-----
Other Investing Activities
-0.091.12-2.960----
Investing Cash Flow
-0.07-0.20.52-3.08-2.040000
Common Stock Issued
00.064.370.397.220.050.0320
Share Repurchases
00001.4400-0.050
Other Financing Activities
1.682.53-1.031.912.030.260.32-0.10.6
Financing Cash Flow
1.682.583.332.37.80.310.341.950.6
Net Cash Flow
0.09-0.01-0.06-8.430.02-0.16-0.890.980.03
Free Cash Flow
-1.59-2.64-4.09-10.85-6.29-0.47-1.23-0.96-0.57
Free Cash Flow Margin
-66.66%-162.47%-198.34%-120.28%-1818.88%----266515.49%
Free Cash Flow Per Share
-0.10-0.18-0.23-0.64-5.19-0.10-0.04-0.05-0.04
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.